Colin Hislop
2011 - Anthera Pharmaceuticals
In 2011, Colin Hislop earned a total compensation of $781K as Chief Medical Officer at Anthera Pharmaceuticals, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $40,222 |
|---|---|
| Option Awards | $342,102 |
| Salary | $338,333 |
| Stock Awards | $60,333 |
| Total | $780,990 |
Hislop received $342.1K in option awards, accounting for 44% of the total pay in 2011.
Hislop also received $40.2K in non-equity incentive plan, $338.3K in salary and $60.3K in stock awards.
Rankings
In 2011, Colin Hislop's compensation ranked 6,550th out of 10,747 executives tracked by ExecPay. In other words, Hislop earned more than 39.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,550 out of 10,747 | 39th |
Division Manufacturing | 2,376 out of 3,960 | 40th |
Major group Chemicals And Allied Products | 554 out of 1,038 | 47th |
Industry group Drugs | 365 out of 786 | 54th |
Industry Pharmaceutical Preparations | 289 out of 571 | 49th |
Source: SEC filing on April 28, 2014.
Hislop's colleagues
We found five more compensation records of executives who worked with Colin Hislop at Anthera Pharmaceuticals in 2011.
2011
Paul Truex
Anthera Pharmaceuticals
Chief Executive Officer
2011
Christopher Lowe
Anthera Pharmaceuticals
Chief Financial Officer
2011
Debra Odink
Anthera Pharmaceuticals
Chief Technology Officer
2011
Georgina Kilfoil
Anthera Pharmaceuticals
Senior Vice President, Product Development
2011
May Liu
Anthera Pharmaceuticals